| Literature DB >> 26272755 |
Romain Guinamard1, Patrice Bouvagnet2, Thomas Hof3, Hui Liu4, Christophe Simard3, Laurent Sallé3.
Abstract
TRPM4 forms a non-selective cation channel activated by internal Ca(2+). Its functional expression was demonstrated in cardiomyocytes of several mammalian species including humans, but the channel is also present in many other tissues. The recent characterization of the TRPM4 inhibitor 9-phenanthrol, and the availability of transgenic mice have helped to clarify the role of TRPM4 in cardiac electrical activity, including diastolic depolarization from the sino-atrial node cells in mouse, rat, and rabbit, as well as action potential duration in mouse cardiomyocytes. In rat and mouse, pharmacological inhibition of TRPM4 prevents cardiac ischaemia-reperfusion injuries and decreases the occurrence of arrhythmias. Several studies have identified TRPM4 mutations in patients with inherited cardiac diseases including conduction blocks and Brugada syndrome. This review identifies TRPM4 as a significant actor in cardiac electrophysiology. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Arrhythmias; Brugada; Calcium-activated non-selective cation channel; Cardioprotection; TRPM4
Mesh:
Substances:
Year: 2015 PMID: 26272755 DOI: 10.1093/cvr/cvv213
Source DB: PubMed Journal: Cardiovasc Res ISSN: 0008-6363 Impact factor: 10.787